Zynerba Pharmaceuticals (ZYNE) - 3 Year Stock Split History

Historical stock splits for Zynerba Pharmaceuticals since 2015. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Zynerba Pharmaceuticals Annual Stock Splits
Zynerba Pharmaceuticals Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.111B $0.000B
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal cannabinoid therapeutics for indications including refractory epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $62.621B 10.74
Teva Pharmaceutical Industries (TEVA) Israel $22.849B 6.38
Mylan (MYL) United Kingdom $19.499B 8.29
Bausch Health Cos (BHC) Canada $7.285B 5.44
Dr Reddy's Laboratories (RDY) India $5.340B 23.85
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.698B 4.59
Akorn (AKRX) United States $2.422B 11.99
Supernus Pharmaceuticals (SUPN) United States $2.258B 24.16
Assembly Biosciences (ASMB) United States $0.913B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.809B 116.67
CymaBay Therapeutics (CBAY) United States $0.706B 0.00
Homology Medicines (FIXX) United States $0.622B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.604B 0.00
Voyager Therapeutics (VYGR) United States $0.593B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.590B 0.00
Corium (CORI) United States $0.319B 0.00
Teligent (TLGT) United States $0.225B 0.00
Sol-Gel Technologies (SLGL) Israel $0.118B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.067B 0.00
Aevi Genomic Medicine (GNMX) United States $0.066B 0.00
Versartis (VSAR) United States $0.062B 0.00
Evoke Pharma (EVOK) United States $0.039B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.022B 0.00
Acasti Pharma (ACST) Canada $0.017B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00
Agile Therapeutics (AGRX) United States $0.009B 0.00